Bedfordshire and Luton Joint Formulary Formulary

Formulary items found

Status	Description	Section
RED	Secukinumab 150mg Cosentyx^® (Pre-filled pen or syringe)	Musculoskeletal and joint diseases, Cytokine modulators, 10.01.03
RED	Secukinumab 150mg Cosentyx^® (Pre-filled pen or syringe)	Skin, Drugs affecting the immune response, 13.05.03

Links found

NICE TA 719 Secukinumab for treating non-radiographic axial spondyloarthritis, Technology appraisal guidance
NICE TA350: Secukinumab for treating moderate to severe plaque psoriasis
NICE TA407: Secukinumab for active ankylosing spondylitis after treatment with NSAIDs or TNF-alpha inhibitors
NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs
NICE TA734: Secukinumab for treating moderate to severe plaque psoriasis in children and young people
NICE TA935: Secukinumab for treating moderate to severe hidradenitis suppurativa